Comparison of the long‐term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study
出版年份 2020 全文链接
标题
Comparison of the long‐term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study
作者
关键词
-
出版物
CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-02-10
DOI
10.1002/cncr.32700
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study
- (2019) Freija Verdoodt et al. CLINICAL INFECTIOUS DISEASES
- Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
- (2018) María Paz-Zulueta et al. BMC CANCER
- Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study
- (2018) Rengaswamy Sankaranarayanan et al. VACCINE
- Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain
- (2017) Esther Navarro-Illana et al. VACCINE
- Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials
- (2017) Matti Lehtinen et al. BMJ Open
- Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
- (2017) Karen Canfell et al. PLOS MEDICINE
- Trends in Cervical Cancer Screening in Title X-Funded Health Centers — United States, 2005–2015
- (2017) Christina I. Fowler et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016
- (2017) Tanja Y. Walker et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
- (2016) Suzanne M. Garland et al. CLINICAL INFECTIOUS DISEASES
- Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study
- (2016) Ana M. Rodriguez et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
- (2016) Rengaswamy Sankaranarayanan et al. LANCET ONCOLOGY
- An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls
- (2016) Robine Donken et al. Human Vaccines & Immunotherapeutics
- Less than 3 doses of the HPV vaccine – Review of efficacy against virological and disease end points
- (2016) Partha Basu et al. Human Vaccines & Immunotherapeutics
- Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination
- (2016) Anna Louise Beavis et al. Frontiers in Oncology
- Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550 000 Young Girls
- (2015) Maria Blomberg et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
- (2015) Aimée R Kreimer et al. LANCET ONCOLOGY
- Trends and Patterns of Sexual Behaviors Among Adolescents and Adults Aged 14 to 59 Years, United States
- (2015) Gui Liu et al. SEXUALLY TRANSMITTED DISEASES
- Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
- (2015) Geraldine Dominiak-Felden et al. PLoS One
- Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease
- (2014) E. A. Joura et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide
- (2014) Laia Alemany et al. INTERNATIONAL JOURNAL OF CANCER
- Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma
- (2014) Eva Herweijer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
- (2014) E. Crowe et al. BMJ-British Medical Journal
- Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
- (2013) Dorota M Gertig et al. BMC Medicine
- Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva
- (2013) Silvia de Sanjosé et al. EUROPEAN JOURNAL OF CANCER
- Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer
- (2013) Seoyoung C. Kim et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Sexually Transmitted Infections Among US Women and Men
- (2013) Catherine Lindsey Satterwhite et al. SEXUALLY TRANSMITTED DISEASES
- Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer
- (2012) Carol Chelimo et al. JOURNAL OF INFECTION
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
- (2012) Debbie Saslow et al. Journal of Lower Genital Tract Disease
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years
- (2009) Cosette M. Wheeler et al. JOURNAL OF INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started